These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 32470601)

  • 1. Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification.
    Wang Q; Hu Z
    Int J Infect Dis; 2020 Jul; 96():618-620. PubMed ID: 32470601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of plasma exchange in association with higher dose CVVH in Cytokine Storm Complicating COVID-19.
    Lin JH; Chen YC; Lu CL; Hsu YN; Wang WJ
    J Formos Med Assoc; 2020 Jun; 119(6):1116-1118. PubMed ID: 32359878
    [No Abstract]   [Full Text] [Related]  

  • 3. Extracorporeal Hemoadsorption: An Option for COVID-19-Associated Cytokine Storm Syndrome.
    Napp LC; Bauersachs J
    Shock; 2020 Nov; 54(5):700-701. PubMed ID: 32453251
    [No Abstract]   [Full Text] [Related]  

  • 4. Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients.
    Cala-García JD; Sierra-Bretón JD; Cavelier-Baiz JE; Faccini-Martínez ÁA; Pérez-Díaz CE
    Immunotherapy; 2020 Oct; 12(15):1127-1132. PubMed ID: 32664810
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019].
    Chen C; Zhang XR; Ju ZY; He WF
    Zhonghua Shao Shang Za Zhi; 2020 Jun; 36(6):471-475. PubMed ID: 32114747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weathering the Cytokine Storm in COVID-19: Therapeutic Implications.
    Iannaccone G; Scacciavillani R; Del Buono MG; Camilli M; Ronco C; Lavie CJ; Abbate A; Crea F; Massetti M; Aspromonte N
    Cardiorenal Med; 2020; 10(5):277-287. PubMed ID: 32599589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic plasma exchange in life-threatening COVID-19 and associated cytokine release syndrome.
    Faqihi F; Alharthy A; Karakitsos D
    J Formos Med Assoc; 2020 Dec; 119(12):1888-1889. PubMed ID: 32680687
    [No Abstract]   [Full Text] [Related]  

  • 8. A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management.
    Verma A; Adhikary A; Woloschak G; Dwarakanath BS; Papineni RVL
    Int J Radiat Biol; 2020 Nov; 96(11):1323-1328. PubMed ID: 32910699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to Letter to the Editor: Therapeutic plasma exchange resolving COVID-19 related ARDS.
    Lin JH; Lu CL; Wu HJ; Wang WJ
    J Formos Med Assoc; 2020 Dec; 119(12):1890-1892. PubMed ID: 32773258
    [No Abstract]   [Full Text] [Related]  

  • 10. On the Alert for Cytokine Storm: Immunopathology in COVID-19.
    Henderson LA; Canna SW; Schulert GS; Volpi S; Lee PY; Kernan KF; Caricchio R; Mahmud S; Hazen MM; Halyabar O; Hoyt KJ; Han J; Grom AA; Gattorno M; Ravelli A; De Benedetti F; Behrens EM; Cron RQ; Nigrovic PA
    Arthritis Rheumatol; 2020 Jul; 72(7):1059-1063. PubMed ID: 32293098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intervention timing of invasive mechanical ventilation and extracorporeal membrane oxygenation in the treatment of severe COVID-19].
    Xia JG; Li M; Zhan QY
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Sep; 43(9):725-728. PubMed ID: 32894906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19.
    Ma J; Xia P; Zhou Y; Liu Z; Zhou X; Wang J; Li T; Yan X; Chen L; Zhang S; Qin Y; Li X
    Clin Immunol; 2020 May; 214():108408. PubMed ID: 32247038
    [No Abstract]   [Full Text] [Related]  

  • 13. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.
    Ye Q; Wang B; Mao J
    J Infect; 2020 Jun; 80(6):607-613. PubMed ID: 32283152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption.
    Yiğenoğlu TN; Ulas T; Dal MS; Korkmaz S; Erkurt MA; Altuntaş F
    Transfus Apher Sci; 2020 Aug; 59(4):102855. PubMed ID: 32636114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients.
    Convertino I; Tuccori M; Ferraro S; Valdiserra G; Cappello E; Focosi D; Blandizzi C
    Crit Care; 2020 Jun; 24(1):331. PubMed ID: 32527304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2019 Novel Coronavirus Pandemic: What Do We Know?
    Margallo LN; Diaz M; Lim PP
    S D Med; 2020 Jun; 73(6):262-264. PubMed ID: 32580258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment.
    Prete M; Favoino E; Catacchio G; Racanelli V; Perosa F
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
    Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
    J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19: Cytokine storm modulation/blockade with oral polyvalent immunoglobulins (PVIG, KMP01D): A potential and safe therapeutic agent (
    Sly LM; Braun P; Woodcock BG
    Int J Clin Pharmacol Ther; 2020 Dec; 58(12):678-686. PubMed ID: 33141018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.